Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity.

AIMS: Obesity is a primary contributor to acquired insulin resistance leading to the development of type 2 diabetes and cardiovascular alterations. The carnitine derivate, propionyl-L-carnitine (PLC), plays a key role in energy control. Our aim was to evaluate metabolic and cardiovascular effects of...

Full description

Bibliographic Details
Main Authors: Carmen Mingorance, Lucie Duluc, Matthieu Chalopin, Gilles Simard, Pierre-Henri Ducluzeau, Maria Dolores Herrera, Maria Alvarez de Sotomayor, Ramaroson Andriantsitohaina
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3311627?pdf=render
_version_ 1818305782191489024
author Carmen Mingorance
Lucie Duluc
Matthieu Chalopin
Gilles Simard
Pierre-Henri Ducluzeau
Maria Dolores Herrera
Maria Alvarez de Sotomayor
Ramaroson Andriantsitohaina
author_facet Carmen Mingorance
Lucie Duluc
Matthieu Chalopin
Gilles Simard
Pierre-Henri Ducluzeau
Maria Dolores Herrera
Maria Alvarez de Sotomayor
Ramaroson Andriantsitohaina
author_sort Carmen Mingorance
collection DOAJ
description AIMS: Obesity is a primary contributor to acquired insulin resistance leading to the development of type 2 diabetes and cardiovascular alterations. The carnitine derivate, propionyl-L-carnitine (PLC), plays a key role in energy control. Our aim was to evaluate metabolic and cardiovascular effects of PLC in diet-induced obese mice. METHODS: C57BL/6 mice were fed a high-fat diet for 9 weeks and then divided into two groups, receiving either free- (vehicle-HF) or PLC-supplemented water (200 mg/kg/day) during 4 additional weeks. Standard diet-fed animals were used as lean controls (vehicle-ST). Body weight and food intake were monitored. Glucose and insulin tolerance tests were assessed, as well as the HOMA(IR), the serum lipid profile, the hepatic and muscular mitochondrial activity and the tissue nitric oxide (NO) liberation. Systolic blood pressure, cardiac and endothelial functions were also evaluated. RESULTS: Vehicle-HF displayed a greater increase of body weight compared to vehicle-ST that was completely reversed by PLC treatment without affecting food intake. PLC improved the insulin-resistant state and reversed the increased total cholesterol but not the increase in free fatty acid, triglyceride and HDL/LDL ratio induced by high-fat diet. Vehicle-HF exhibited a reduced cardiac output/body weight ratio, endothelial dysfunction and tissue decrease of NO production, all of them being improved by PLC treatment. Finally, the decrease of hepatic mitochondrial activity by high-fat diet was reversed by PLC. CONCLUSIONS: Oral administration of PLC improves the insulin-resistant state developed by obese animals and decreases the cardiovascular risk associated to this metabolic alteration probably via correction of mitochondrial function.
first_indexed 2024-12-13T06:32:03Z
format Article
id doaj.art-685b4374bb5c4f43a9f0e299355908da
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T06:32:03Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-685b4374bb5c4f43a9f0e299355908da2022-12-21T23:56:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0173e3426810.1371/journal.pone.0034268Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity.Carmen MingoranceLucie DulucMatthieu ChalopinGilles SimardPierre-Henri DucluzeauMaria Dolores HerreraMaria Alvarez de SotomayorRamaroson AndriantsitohainaAIMS: Obesity is a primary contributor to acquired insulin resistance leading to the development of type 2 diabetes and cardiovascular alterations. The carnitine derivate, propionyl-L-carnitine (PLC), plays a key role in energy control. Our aim was to evaluate metabolic and cardiovascular effects of PLC in diet-induced obese mice. METHODS: C57BL/6 mice were fed a high-fat diet for 9 weeks and then divided into two groups, receiving either free- (vehicle-HF) or PLC-supplemented water (200 mg/kg/day) during 4 additional weeks. Standard diet-fed animals were used as lean controls (vehicle-ST). Body weight and food intake were monitored. Glucose and insulin tolerance tests were assessed, as well as the HOMA(IR), the serum lipid profile, the hepatic and muscular mitochondrial activity and the tissue nitric oxide (NO) liberation. Systolic blood pressure, cardiac and endothelial functions were also evaluated. RESULTS: Vehicle-HF displayed a greater increase of body weight compared to vehicle-ST that was completely reversed by PLC treatment without affecting food intake. PLC improved the insulin-resistant state and reversed the increased total cholesterol but not the increase in free fatty acid, triglyceride and HDL/LDL ratio induced by high-fat diet. Vehicle-HF exhibited a reduced cardiac output/body weight ratio, endothelial dysfunction and tissue decrease of NO production, all of them being improved by PLC treatment. Finally, the decrease of hepatic mitochondrial activity by high-fat diet was reversed by PLC. CONCLUSIONS: Oral administration of PLC improves the insulin-resistant state developed by obese animals and decreases the cardiovascular risk associated to this metabolic alteration probably via correction of mitochondrial function.http://europepmc.org/articles/PMC3311627?pdf=render
spellingShingle Carmen Mingorance
Lucie Duluc
Matthieu Chalopin
Gilles Simard
Pierre-Henri Ducluzeau
Maria Dolores Herrera
Maria Alvarez de Sotomayor
Ramaroson Andriantsitohaina
Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity.
PLoS ONE
title Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity.
title_full Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity.
title_fullStr Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity.
title_full_unstemmed Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity.
title_short Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity.
title_sort propionyl l carnitine corrects metabolic and cardiovascular alterations in diet induced obese mice and improves liver respiratory chain activity
url http://europepmc.org/articles/PMC3311627?pdf=render
work_keys_str_mv AT carmenmingorance propionyllcarnitinecorrectsmetabolicandcardiovascularalterationsindietinducedobesemiceandimprovesliverrespiratorychainactivity
AT lucieduluc propionyllcarnitinecorrectsmetabolicandcardiovascularalterationsindietinducedobesemiceandimprovesliverrespiratorychainactivity
AT matthieuchalopin propionyllcarnitinecorrectsmetabolicandcardiovascularalterationsindietinducedobesemiceandimprovesliverrespiratorychainactivity
AT gillessimard propionyllcarnitinecorrectsmetabolicandcardiovascularalterationsindietinducedobesemiceandimprovesliverrespiratorychainactivity
AT pierrehenriducluzeau propionyllcarnitinecorrectsmetabolicandcardiovascularalterationsindietinducedobesemiceandimprovesliverrespiratorychainactivity
AT mariadoloresherrera propionyllcarnitinecorrectsmetabolicandcardiovascularalterationsindietinducedobesemiceandimprovesliverrespiratorychainactivity
AT mariaalvarezdesotomayor propionyllcarnitinecorrectsmetabolicandcardiovascularalterationsindietinducedobesemiceandimprovesliverrespiratorychainactivity
AT ramarosonandriantsitohaina propionyllcarnitinecorrectsmetabolicandcardiovascularalterationsindietinducedobesemiceandimprovesliverrespiratorychainactivity